PALATIN TECHNOLOGIES, INC. Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss
PALATIN TECHNOLOGIES, INC. (PTN) reported Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss of -$119.35 thousand for the 12-month period ending 2011-06-30, per its 10-K filed 2013-09-27.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2013-09-27
- PALATIN TECHNOLOGIES, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2011-06-30 was -$238.69K.
- PALATIN TECHNOLOGIES, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2011-03-31 was $58.96K.
- PALATIN TECHNOLOGIES, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2010-12-31 was $60.39K.
- PALATIN TECHNOLOGIES, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2011 was -$119.35K.
| Period end | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 3 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 9 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month as first filed |
|---|---|---|---|---|---|
| 2011-06-30 | -$238.69K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-27 | -$179.74K derived: sum of 2 quarters · filed 2013-09-27 | -$119.35K derived: sum of 3 quarters · filed 2013-09-27 | -$119.35K 10-K · filed 2013-09-27 | $119.35K 10-K · filed 2012-09-10 |
| 2011-03-31 | $58.96K 10-Q · filed 2012-05-14 | $119.35K derived: sum of 2 quarters · filed 2012-05-14 | $119.35K 10-Q · filed 2012-05-14 | ||
| 2010-12-31 | $60.39K 10-Q · filed 2012-02-14 | $60.39K 10-Q · filed 2012-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |